Found 11 matching trials
18F-FLUC PET/MR in Patients With Brain Mets
PHASE3The goal of this clinical trial is to use new imaging methods to help in fi...
Location
University of Wisconsin
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
N/AFluciclovine F18 (Axumin) has been demonstrated to provide good delineation...
Location
UVM Medical Center
FACBC PET/CT for Recurrent Prostate Cancer
PHASE2Hypothesis:Anti-\[18F\]FACBC PET-CT will adequately detect local and extrap...
Location
Emory University Hospital
Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule
PHASE1This study will look at how the \[18\]FACBC goes into the lung nodules. Thi...
High Resolution PET-MRI Before Prostate Cancer HIFU
PHASE2This prospective trial aims to determine if enhanced prostate imaging using...
Location
Cedars-Sinai Medical Center
FACBC Prostate Therapy Response
PHASE2The purpose of this study is to assess if using anti-1-amino-3-\[18F\]fluor...
Location
Emory University Hospital
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
PHASE2This study is for patients who have had surgery to remove brain metastasis ...
Location
Miami Cancer Institute at Baptist Health South Florida
Defining Recurrent Disease With Axuminβ’
N/AThis project seeks to use advanced imaging (specifically, positron emission...
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
EARLY_PHASE1This research study is studying a positron emission tomography (PET) agent ...
Location
Dana Farber Cancer Institute
Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease
NAThe purpose of this study is to look at whether F-18 Fluciclovine (i.e. Axu...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center